eXTReMe Tracker
Gene Therapy Net RSS feed Follow Gene Therapy Net on Twitter LinkedIn - Gene Therapy Net discussion group Facebook - Gene Therapy Net

Newsletter August 2016

Gene Therapy Net Banner
News: FDA Grants Breakthrough Designation to AveXis's Gene Therapy
AveXis, a clinical-stage gene therapy company developing treatments for patients suffering from rare and life-threatening neurological genetic diseases, announced the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation for AVXS-101, the company's lead development candidate for the treatment of spinal muscular atrophy (SMA) Type 1 in pediatric patients. The Breakthrough Therapy Designation is based on preliminary clinical results from the ongoing trial of AVXS-101, conducted in collaboration with The Research Institute at Nationwide Children's Hospital and The Ohio State University.

News: Ziopharm Confirms Three Patient Deaths in Gene Therapy Trial
Zopharm Oncology has disclosed the deaths of three patients in a Phase I study of its gene therapy candidate Ad-RTS-hIL-12 plus oral veledimex for a form of brain cancer. The third patient died of an intracranial hemorrhage that occurred sometime following discharge from a treating center for the Phase I study, Ziopharm said today in a statement. The study is designed to assess the combination of Ad-RTS-hIL-12 with orally administered veledimex in patients with recurrent or progressive glioblastoma (GBM) or grade III malignant glioma.

Conference: 3rd Cell & Gene Therapy Conference
We invite you to attend the 3rd Cell & Gene Therapy Conference, which will take place September 12-13, 2016 in Boston, MA. The conference will bring together an exciting balance of industry and academia, so that delegates have the unique opportunity to network with colleagues and gain fresh perspective on the various research.

Treatment of disease using cell and gene therapy is now a reality. With emerging technologies and new clinical trials being developed and launched at a growing rate, this meeting will discuss the evolving regulatory challenges and pre-clinical requirements, emerging technologies, the development and applications of cell and gene therapy, as well as business models and commercial milestones.

Register today with the code (XMKTJC30) for 30% off!


Company: VIVEbioTECH S.L.
VIVEbioTECH S.L. is a Spanish biotech company which specialises in gene transfer technologies, and in particular those related to the production of viral vectors under GMP conditions, and their gene therapy applications.



- 18 – 19 August 2016, Gene Therapy Bioproduction conference, Boston, MA
- 12 -13 September 2016, 3rd Cell & Gene Therapy Conference, Boston, MA
- 14 -16 September 2016, 22th Annual Meeting of the German Society for Gene Therapy (DG-GT e.V.), Heidelberg, Germany
- 20 -21 September 2016, Second Annual Gene Therapy Breakthroughs, Boston, MA
- 21 -22 September 2016, Phacilitate's Cell & Gene Therapy Europe, Berlin, Germany
- 23 -24 September 2016, 1st Congress of the Hellenic Society of Gene Therapy and Regenerative Medicine, Thessaloniki, Greece
- 1 - 5 October 2016, International Meeting on Replicating Oncolytic Virus Therapeutics, Vancouver, Canada
- 5 – 7 October 2016, Cell & Gene Therapy BioProcessing & Commercialization meeting, Boston, MA
- 10 – 11 October 2016, Adoptive T-Cell Therapy Summit Europe 2016, London, UK
- 18 – 21 October 2016, XXIV Congress of the European Society of Gene and Cell Therapy (ESGCT) and the International Society for Stem Cell Research, Florence, Italy
- 21 October 2016, Second European debate on Germline Gene Editing at ESGCT-ISSCR Congress, Florence, Italy
- 3 - 4 November 2016, 2nd Annual Cell & Gene Therapy Congress 2016, London, UK
- 16 – 18 November 2016, 15th Annual Gene Therapy Symposium for Heart, Lung, and Blood Diseases, Sonoma, California
- 29 - 30 November 2016, Cell Therapy Manufacturing & Gene Therapy Congress, Amsterdam, the Netherlands
- 6 - 7 February 2017, 2nd Annual Genome Editing & Engineering Conference, San Diego, CA
- 6 - 8 March 2017, International Society for BioProcess Technology 7th Spring Meeting - Viral vectors and vaccines, Washington, DC
- 16 - 17 March 2017, Spring Symposium of the Netherlands Society of Gene & Cell Therapy (NVGCT), Lunteren, The Netherlands
- 29 - 30 March 2017, 19th International Conference on Cell and Gene Therapy - ICCGT 2017, Singapore
- 19 - 21 April 2017, Annual conference of the British Society for Gene and Cell Therapy (BSGCT), Cardiff, Wales, UK
- 3 - 6 May 2017,International Society for Cellular Therapy (ISCT) 23th Annual Meeting, London, UK
- 10 - 13 May 2017, American Society of Gene and Cell Therapy (ASGCT) 20th Annual Meeting, Washington, DC
- 14 - 19 May 2017, Gordon Research Conference: Virusses & Cells, Lucca, Italy
- 24 - 26 May 2017, 10th Australasian Gene Therapy Society Meeting (AGCTS), Sydney, Australia
- 27 - 28 November 2017, 19th International Conference on Cell and Gene Therapy - ICCGT 2017, Istanbul, Turkey


Gene Therapy Net is the information resource for basic and clinical research in gene therapy, and the site serves as a network in the exchange of gene therapy information and breaking news items. Visitors can keep track of the latest scientific papers, conference announcements, gene therapy jobs, regulations and guidelines. Other information websites created and maintained by the owner of Gene Therapy Net are Dengue Virus Net, Influenza Virus Net, Ebola Virus Net, Chikungunya Virus Net and Zika Virus Net.
To unsubscribe from the Newsletter, please login and edit your subscription details or contact us. You are currently registered as: {subtag:name}, email address: {subtag:email}.

Advertise on this site?